Thermo Fisher Scientific Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
610.36 USD | -0.62% | -2.14% | +15.08% |
09-16 | Thermo Fisher Likely to Update Growth Plan, Focus on Business Lines, Services, UBS Says | MT |
09-16 | UBS Raises Thermo Fisher Scientific Price Target to $700 From $670, Maintains Buy Rating | MT |
Capitalization | 235B 319B | P/E ratio 2024 * |
38.2x | P/E ratio 2025 * | 33.4x |
---|---|---|---|---|---|
Enterprise value | 232B 315B | EV / Sales 2024 * |
6.03x | EV / Sales 2025 * | 5.57x |
Free-Float |
86.05% | Yield 2024 * |
0.24% | Yield 2025 * | 0.26% |
Last Transcript: Thermo Fisher Scientific Inc.
1 day | +0.49% | ||
1 week | -1.01% | ||
Current month | -0.15% | ||
1 month | +1.68% | ||
3 months | +7.36% | ||
6 months | +5.14% | ||
Current year | +15.70% |
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 23-09-30 |
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 66 | 06-11-08 |
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Tyler Jacks
BRD | Director/Board Member | 63 | 09-05-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 18 M€ | +10.05% | - | |
5.37% | 2 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.49% | -1.01% | +19.13% | +9.58% | 235B | ||
+0.65% | +1.08% | +8.14% | -14.81% | 199B | ||
+0.31% | +2.50% | +66.27% | +42.57% | 175B | ||
+0.24% | +1.04% | +57.86% | +85.99% | 123B | ||
-0.76% | -1.38% | +9.15% | -14.52% | 61.32B | ||
+1.23% | +5.55% | -5.25% | -42.53% | 41.78B | ||
-0.31% | +1.79% | +30.42% | - | 39.57B | ||
-0.20% | -4.31% | -16.42% | -29.48% | 39.5B | ||
+0.73% | +0.16% | +19.33% | -20.18% | 39.74B | ||
+1.14% | +0.89% | +73.17% | -12.02% | 36.99B | ||
Average | +0.47% | +0.89% | +26.18% | +0.51% | 99.05B | |
Weighted average by Cap. | +0.46% | +1.05% | +29.45% | +12.86% |
2024 * | 2025 * | |
---|---|---|
Net sales | 42.92B 58.33B | 45.6B 61.98B |
Net income | 6.14B 8.35B | 6.93B 9.41B |
Net Debt | 24.14B 32.82B | 19.34B 26.28B |
Date | Price | Change | Volume |
---|---|---|---|
24-09-17 | 610.82 $ | -0.54% | 608,613 |
24-09-16 | 614.15 $ | +0.49% | 1,198,221 |
24-09-13 | 611.17 $ | -0.49% | 1,125,097 |
24-09-12 | 614.16 $ | -0.70% | 1,397,629 |
24-09-11 | 618.46 $ | -0.92% | 1,324,098 |
Delayed Quote Nyse, September 16, 2024 at 04:00 pm
More quotes- Stock Market
- Equities
- TMO Stock
MarketScreener is also available in this country: United States.
Switch edition